澳優(01717.HK)2023年權益持有人應占純利1.74億元 同比下跌19.4%
格隆匯3月27日丨澳優(01717.HK)發佈公吿,2023年,公司收入為人民幣7,382.0百萬元,同比下跌人民幣413.5百萬元或5.3%。毛利為人民幣2,852.6百萬元,同比下跌人民幣540.2百萬元或15.9%。公司權益持有人應占純利為人民幣174.4百萬元,同比下跌人民幣42.1百萬元或19.4%。儘管如此,公司自家品牌配方羊奶粉於中國市場佔有率穩居第一,從國際業務來看,佳貝艾特羊奶粉在全球多個市場實現高速增長,持續保持全球羊奶粉第一的市場地位;自家品牌配方牛奶粉盈利能力同比改善,營養品業務收入持續快速增長。
公司董事會建議派付2023年度末期股息每股公司股份0.05港元(2022年:0.06港元)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.